Rare diseases
Investigational molecules
Locations
Via Portuense 292, 00149 Rome, Italy
Research activity includes COVID-19 infection and infectious diseases of the respiratory system, with attention to the durability of humoral immunity and cellular immunity after infection and treatment with monoclonal antibodies. The clinical focus also covers the effect of prior vaccination status on immune response.
These studies are centered in Rome and reflect ongoing interest in immune recovery after SARS-CoV-2 infection.
National Institute For Infectious Diseases Lazzaro Spallanzani runs clinical trials in conditions such as Pulmonary tuberculosis, Respiratory tract infection, COVID-19, Respiratory tract infection viral, among others.
Clinical trials run by this sponsor – those enrolling participants first.
ItalyItalyItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
